Avi Polymers Ka Naya Game Plan: AI Health Tech Mein Entry + Dividend Ka Fayda!

TECH
Whalesbook Logo
AuthorAnanya Iyer|Published at:
Avi Polymers Ka Naya Game Plan: AI Health Tech Mein Entry + Dividend Ka Fayda!
Overview

Avi Polymers ekdum naya scene bana raha hai! Chemical trading chhodkar ab woh AI Health Tech sector mein ghus rahe hain apni subsidiary AVI AI Technologies ke through. Kal Monday ko Board ki meeting hai jahan yeh move approve hoga, aur saath mein FY25-26 ke results bhi dekhenge aur **50%** tak ka dividend dene par bhi विचार hoga.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

AI Health Tech Mein Entry Ki Wajah?

Company ka kehna hai ki AI Health Tech mein bohot bada growth potential hai, aur woh iska fayda uthana chahte hain. Yeh move unki traditional chemical trading business se kaafi alag hai. Board April 27, 2026 ko milegi yeh sab finalize karne ke liye. Unka goal hai ek diversified, AI-driven digital ecosystem banana.

Dividend Aur Stock Ka Kya Scene Hai?

Board 50% tak ka dividend dene par bhiविचार karegi. Stock ki baat karein toh April 17, 2026 ko share 4.96% tak bhaga tha, lekin usse pehle pichhle mahine yeh 37% gira bhi tha. Company virtually debt-free hai.

KrishiBuddy Aur Market Ka Trend

Yaad hai Avi Polymers ne pehle KrishiBuddy platform launch kiya tha? Woh bhi AI-based hai aur farmers ko support karta hai. Us segment mein toh 2000% tak ka revenue growth dikha hai! AI in Healthcare market abhi bohot fast grow kar raha hai, aur bade players jaise Google, Microsoft, AWS bhi ismein hain. Avi Polymers ka P/E ratio 12.06 hai, jo industry average 67.06 se kaafi kam hai, matlab company undervalued ho sakti hai. Lekin sales growth pehle -
42.0% thi, haalanki recent quarters mein achhi recovery dikhi hai.

Risk Bhi Hai Bhai!

Par haan, AI Health Tech mein ghusna easy nahi hai. Yeh ek highly specialized aur regulated field hai. Company ko nayi expertise aur infrastructure chahiye. Pichhle FY25 mein sales -89.99% giri thi, isliye growth sustain karna ek bada challenge hoga. Promoter holding bhi kam hui hai, jo thoda caution ka signal hai. Healthcare AI development mein validation time bohot lagta hai.

Future Kya Kehta Hai?

AI in Healthcare market 2026 se 2033 tak 38.90% ke CAGR se grow hone ka forecast hai. Toh potential toh bohot hai! Board meeting ke baad AVI AI Technologies ke plans par aur clarity milegi.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.